Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Charlie Hoban

Partner, Health & Life Sciences, Oliver Wyman

As featured in this year's Oliver Wyman Health Innovation Journal, we examine the emerging sparks beginning to define the dimensions of a new healthcare industry.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

In this episode of the Oliver Wyman Health Podcast, we talk what's next for artificial intelligence, machine learning, IoT, and blockchain.

CIO, Beth Israel Deaconess Healthcare System, International Healthcare Innovation Professor, Harvard Medical School
Partner, Health & Life Sciences, Oliver Wyman

From Walmart to Amazon to 23andMe, these 11 market scenarios paint a picture of what disruption looks like, both in and out of healthcare.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Chief Strategy Officer, BCBS of Massachusetts
Principal, Health & Life Sciences, Oliver Wyman

Disruption in healthcare will be driven by the power of its trapped – and highly exploitable – value.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, Oliver Wyman

Oliver Wyman’s Charlie Hoban and Steve Filler were among the more than 38,000 healthcare IT professionals, clinicians, and executives from around the world who converged in Chicago this week for the 2015 Annual HIMSS Conference & Exhibition.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Oliver Wyman

Insights in your inbox

Subscribe

Telemedicine started out as a provider supply solution for outlying rural areas that lacked multiple physicians and specialists. Now, telemedicine is evolving in waves from being a convenient perk to a part of the care continuum to eventually becoming the locus of primary care delivery and care coordination.

Partner, Health & Life Sciences, Oliver Wyman